HLA-DRB1 and myeloid sarcoma: Since we genotyped the whole study group for HLA-DRB1*15:01 rs3135388 G/A to adjust for the significant association of investigated variants with progressive MS disease course, we analyzed whether this variant could have effects on circulatory molecular indicators of processes associated with ferroptosis.